Amphastar Pharmaceuticals, Inc. AMPH

26.13 (0.14) (0.53%) as of 25 Sep
Market cap
$1.1B
P/E
15.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
77.08 249.61 0.00 18.55 502.75 17.92 15.08 21.93 11.29 12.75
P/S ratio
3.29 3.68 3.13 2.81 2.70 2.54 2.74 4.67 2.46 1.74
P/FCF ratio
48.87 144.66 0.00 16,183.62 40.67 15.81 20.93 20.71 10.44 10.53
P/Operating CF
59.93 90.51 97.01 160.35 56.00 27.51 89.92 125.98 61.95 38.09
P/B ratio
2.55 2.65 2.53 2.12 2.11 2.50 2.59 4.70 2.46 1.59
Price to Tangible BV
3.01 3.06 2.87 2.35 2.32 2.74 2.79 115.07 12.70 5.62
EV/Sales
3.15 3.58 2.99 2.68 2.52 2.40 2.54 5.18 2.97 2.19
EV/EBITDA
26.71 59.05 111.51 47.81 27.18 11.25 9.54 13.54 8.23 7.87
EV/Operating CF
20.82 21.90 23.05 20.69 15.41 10.72 14.21 18.19 10.20 10.10
EV/FCF
46.74 140.53 (221.59) 15,426.84 37.95 14.93 19.37 22.99 12.64 13.27
Quick Ratio
1.67 1.70 1.36 1.50 1.57 2.10 2.82 1.66 2.08 2.82
Current Ratio
3.04 2.79 2.06 2.84 2.49 3.06 3.99 2.17 3.07 4.02
Net Debt/EBITDA
(1.22) (1.73) (5.46) (2.35) (1.95) (0.67) (0.77) 1.34 1.43 1.62
Debt/Assets
8.82% 10.45% 9.78% 8.03% 7.36% 11.46% 10.23% 39.00% 38.15% 37.46%
Debt/Equity
0.11 0.14 0.14 0.11 0.10 0.17 0.14 0.92 0.82 0.77
Asset Turnover
0.62 0.55 0.61 0.59 0.57 0.67 0.71 0.57 0.47 0.45
Operating CF/Net income
3.93 10.75 (6.66) 0.85 40.82 1.58 0.98 1.33 1.34 1.59
Capex/Depreciation
(1.46) (2.09) (2.55) (2.29) (1.57) (1.17) (0.94) (0.77) (0.70) (0.62)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
3.14% 1.10% (1.64%) 12.36% 0.32% 13.89% 18.76% 23.55% 23.26% 12.90%
ROA
2.40% 0.83% (1.19%) 8.89% 0.23% 9.54% 12.93% 12.20% 10.32% 6.12%
ROIC
3.28% (0.26%) (1.68%) (0.01%) 1.78% 11.39% 15.76% 12.69% 11.57% 7.88%
Return on Tangible Assets
3.55% 1.21% (1.77%) 12.26% 0.33% 13.55% 17.52% 25.15% 24.26% 12.44%
Average Days of Receivables
38.33 63.88 64.67 51.73 69.27 65.81 65.08 65.40 68.83 81.49
Research and Development Expense of Revenue
16.27% 18.11% 19.54% 21.36% 19.22% 13.92% 14.98% 11.44% 10.10% 11.92%
Selling, General and Administrative Expense of Revenue
18.54% 21.20% 19.70% 19.58% 18.62% 15.74% 13.35% 12.48% 12.91% 18.03%
Intangible Assets out of Total Assets
0.12 0.10 0.08 0.07 0.06 0.06 0.05 0.41 0.37 0.35
Share Based Compensation of Revenue
5.93% 7.11% 5.66% 5.37% 5.86% 4.27% 3.58% 3.14% 3.33% 3.79%
Graham Net Nets
0.10 0.08 0.08 0.11 0.10 0.08 0.12 (0.13) (0.17) (0.16)
Graham Number
6.26 3.54 0.00 14.59 2.93 16.52 21.40 29.10 33.46 28.24
Earnings Yield
1.30% 0.40% (0.65%) 5.39% 0.20% 5.58% 6.63% 4.56% 8.86% 7.84%
Free Cash Flow Yield
2.05% 0.69% (0.43%) 0.01% 2.46% 6.33% 4.78% 4.83% 9.58% 9.49%
Revenue per Share
5.62 5.21 6.35 6.86 7.44 9.16 10.28 13.35 15.11 15.40
Operating CF per Share
0.85 0.85 0.82 0.89 1.22 2.05 1.84 3.80 4.41 3.34
Capex per Share
(0.47) (0.72) (0.91) (0.88) (0.72) (0.57) (0.49) (0.79) (0.85) (0.79)
Free Cash Flow per Share
0.38 0.13 (0.09) 0.00 0.50 1.48 1.35 3.01 3.56 2.55
Cash per Share
1.64 1.57 2.01 1.91 2.33 2.91 3.67 5.37 4.63 6.10
Shareholders Equity per Share
7.26 7.24 7.85 9.10 9.54 9.33 10.89 13.25 15.12 16.88
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
7.26 7.24 7.85 9.10 9.54 9.33 10.89 13.25 15.12 16.88
Free Cash Flow
17.18 6.11 (3.97) 0.21 23.41 70.54 65.57 145.34 172.35 118.98
Working Capital
123.48 120.59 113.51 165.23 167.48 214.31 283.46 264.19 360.31 477.86
Capital Expenditures
(21.38) (33.10) (42.16) (41.55) (33.85) (27.46) (23.61) (38.17) (41.04) (37.13)
Net Current Asset Value
85.61 70.44 71.14 95.80 97.17 92.11 164.99 (383.89) (311.10) (204.48)
EV/EBIT
52.22 0.00 0.00 0.00 80.58 15.03 11.78 16.94 10.59 11.23
Capex to Sales
0.08 0.14 0.14 0.13 0.10 0.06 0.05 0.06 0.06 0.05
Net Profit Margin
3.85% 1.52% (1.95%) 15.18% 0.40% 14.19% 18.31% 21.34% 21.79% 13.63%
Price to Operating Income
54.59 0.00 0.00 0.00 86.36 15.92 12.74 15.26 8.75 8.92
Other line items
Depreciation/Fixed assets
0.10 0.09 0.08 0.08 0.08 0.10 0.11 0.17 0.20 0.19
Cash ROIC
(25.92%) (31.18%) (33.91%) (34.05%) (33.53%) (22.11%) (19.05%) (6.67%) (5.39%) (9.17%)
Accounts Receivable Turnover
8.47 6.98 6.25 6.59 6.24 6.02 5.94 6.30 5.77 4.82
Accounts Payable Turnover
4.92 2.85 2.59 2.32 2.39 2.57 2.88 3.30 2.86 2.38
Inventory Turnover
2.01 2.09 2.82 2.12 1.99 2.51 2.55 2.80 2.76 2.20
Average Days of Payables
114.95 140.36 170.01 147.68 168.80 137.31 122.93 116.20 160.08 148.83
Days of Inventory on Hand
192.82 155.13 134.82 211.79 171.15 142.31 151.16 131.72 156.70 177.46
Average Receivables
30.14 34.42 47.12 48.95 56.04 72.66 83.95 102.22 126.75 149.38
Average Payables
30.71 52.55 72.49 82.23 86.28 92.52 86.89 88.80 125.21 152.70
Average Inventory
75.21 71.68 66.47 89.91 103.67 94.82 98.20 104.71 129.79 165.32
Average Assets
408.94 439.41 482.32 550.27 609.10 651.38 706.76 1,127.45 1,545.19 1,603.38
Average Common Equity
312.38 331.50 349.05 395.94 438.13 447.12 487.09 584.04 685.86 760.55

Fold the line items

Columns are period end dates